Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Mounjaro is a dual-targeting drug as it also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor, making it the first-in-class GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes
Always remember to consult with your healthcare provider for professional advice and never solely depend on self-assessment
TeleSlims assessment protocol includes a medical history review, medication reconciliation, targeted labs when indicated, and evaluation of contraindications to ensure medication safety
doi: 10.1016/j.bbi.2019.04.019 249 MyerD
US$ 29.06
US$ 25.87
US$ 23.29
US$ 28.22
US$ 21.74
